The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial

Kaiyin Chan, Louisa Lui, Kaling Yu, Kwongwai Lau, Manchi Lai, Waiwai Lau, Bacon Ng, Linda L D Zhong, Zhao-Xiang Bian, Kaiyin Chan, Louisa Lui, Kaling Yu, Kwongwai Lau, Manchi Lai, Waiwai Lau, Bacon Ng, Linda L D Zhong, Zhao-Xiang Bian

Abstract

Background: Colorectal cancer is the most common cancer in Hong Kong. Oxaliplatin-based chemotherapy is a major first-line conventional therapy for advanced and metastatic colorectal cancer. However, oxaliplatin causes chemotherapy-induced peripheral neuropathy (CIPN). Acupuncture has long been used to alleviate limb numbness in Chinese medicine. This study aims to examine the efficacy and safety of acupuncture for alleviating CIPN in patients with colorectal cancer in Hong Kong.

Methods/design: This is a single-blinded, randomized, sham-controlled efficacy trial. Eighty-four eligible patients, who are Hong Kong Chinese, aged ≥ 18 years, diagnosed with colorectal cancer and undergoing oxaliplatin-based chemotherapy, will be randomized in a ratio of 1:1 to the electro-acupuncture group or the sham-controlled group. During a 12-week treatment period, patients in the electro-acupuncture group will undergo electro-acupuncture once a week from the first cycle of chemotherapy, while patients in the control group will receive sham acupuncture, and the patients in both groups will be followed up for 12 weeks. The primary outcome measure is the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOC-Ntx) questionnaire. The secondary outcome measures include numerical rating scale (NRS) for numbness/pain, vibration and light touch sense test, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) and Constitution of Chinese Medicine Questionnaire (CCMQ).

Discussion: The study will compare electro-acupuncture with sham acupuncture to explore the feasibility for electro-acupuncture in improving symptoms caused by chemotherapy-induced peripheral neuropathy.

Trial registration: Clinicaltrials.gov, NCT03582423. Registered on 11 July 2018.

Keywords: Acupuncture; Chemotherapy-induced peripheral neuropathy; Colorectal cancer; Oxaliplatin.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Participant flow diagram. CIPN, chemotherapy-induced peripheral neuropathy

References

    1. Hong Kong Cancer Registry. Available from: . Accessed 27 Dec 2019.
    1. NCCN Guidelines for Patients. Colon Cancer, 2018. Available from: . Accessed 27 Dec 2019.
    1. Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013;21(12):3307–3313. doi: 10.1007/s00520-013-1905-5.
    1. SatoJ MM, Nihei S, Takeuchi S, Kashiwaba M, Kudo K. Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision(R)), a pilot study. J Pharm Heal care Sci. 2017;3:21. doi: 10.1186/s40780-017-0089-4.
    1. Kerckhove N, Collin A, Conde S, Chaleteix C, Pezet D, Balayssac D. Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol. 2017;8:86. doi: 10.3389/fphar.2017.00086.
    1. XLW, GLW, JGH Chinese medicine for prevention and treatment of oxaliplatin-induced peripheral neuropathy. Jilin J Cin Med. 2013;5:465–467.
    1. Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review. Crit Rev Oncol Hematol. 2016;98:325–334. doi: 10.1016/j.critrevonc.2015.11.014.
    1. Hershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941–1967. doi: 10.1200/JCO.2013.54.0914.
    1. Greenlee H, Crew KD, Capodice J, et al. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer. Breast Cancer Res Treat. 2016;156(3):453–464. doi: 10.1007/s10549-016-3759-2.
    1. Han X, Wang L, Shi H, et al. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. BMC Cancer. 2017;17(1):40. doi: 10.1186/s12885-016-3037-z.
    1. Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med. 2013;2013:349653. doi: 10.1155/2013/349653.
    1. Derksen TME, Bours MJL, Mols F, Weijenberg MP. Lifestyle-Related Factors in the Self-management of chemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review. Evid Based Complement Alternat Med. 2017;2017:7916031. doi: 10.1155/2017/7916031.
    1. Checklist for items in STRICTA 2010. Published 2010. Available from: . Accessed 27 Dec 2019.
    1. Lu Zhaoxue, Moody Jennifer, Marx Benjamin L., Hammerstrom Tracy. Treatment of Chemotherapy-Induced Peripheral Neuropathy in Integrative Oncology: A Survey of Acupuncture and Oriental Medicine Practitioners. The Journal of Alternative and Complementary Medicine. 2017;23(12):964–970. doi: 10.1089/acm.2017.0052.
    1. Shin K, Kim J, Lee S, et al. Acupuncture for lateral epicondylitis (tennis elbow): study protocol for a randomized, practitioner-assessor blinded, controlled pilot clinical trial. Trials. 2013;14(1):1. doi: 10.1186/1745-6215-14-174.
    1. Xie C-C, Wen X-Y, Jiang L, Xie M-J, Fu WB. Validity of the “streitberger” needle in a chinese population with acupuncture: a randomized, single-blinded, and crossover pilot study. Evid Based Complement Alternat Med. 2013;2013:251603. doi: 10.1155/2013/251603.
    1. Fleckenstein J, Baeumler PI, Gurschler C, et al. Acupuncture for post anaesthetic recovery and postoperative pain: study protocol for a randomised controlled trial. Trials. 2014;15(1):1–9. doi: 10.1186/1745-6215-15-292.
    1. Man S, Hung BHB, Ng RMK, et al. A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression. BMC Complement Altern Med. 2014;14(1):1–8. doi: 10.1186/1472-6882-14-255.
    1. Huang HQ, Brady MF, Cella D, Fleming G. Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study. Int J Gynecol Cancer. 2007;17(2):387–393. doi: 10.1111/j.1525-1438.2007.00794.x.
    1. Calhoun EA, Welshman EE, Chang C-H, et al. Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer. 2003;13(6):741–748.
    1. Gewandter JS, Dworkin RH, Finnerup NB, Mohile NA. Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology? Pain. 2017;158(1):30–33. doi: 10.1097/j.pain.0000000000000653.
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365.
    1. Wong Wendy, Lam Cindy Lo Kuen, Wong Vivian Taam, Yang Zhi Min, Ziea Eric T. C., Kwan Andrew Ka Lun. Validation of the Constitution in Chinese Medicine Questionnaire: Does the Traditional Chinese Medicine Concept of Body Constitution Exist? Evidence-Based Complementary and Alternative Medicine. 2013;2013:1–14. doi: 10.1155/2013/492976.
    1. Wong W, Lam CLK, Su Y-C, et al. Measuring body constitution: validation of the Body Constitution Questionnaire (BCQ) in Hong Kong. Complement Ther Med. 2014;22(4):670–682. doi: 10.1016/j.ctim.2014.05.009.
    1. Griffith KA, Dorsey SG, Renn CL, et al. Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. J Peripher Nerv Syst. 2014;19(2):127–135. doi: 10.1111/jns5.12064.
    1. Ogawa K, Ogawa M, Nishijima K, Tsuda M, Nishimura G. Efficacy of contact needle therapy for chemotherapy-induced peripheral neuropathy. Evid Based Complement Alternat Med. 2013;2013:928129. doi: 10.1155/2013/928129.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj